J1260 Dolasetron mesylate
Also known as: Anzemet, dolasetron
Dolasetron mesylate injection, a 5-hydroxytryptamine 3 receptor antagonist for prevention of nausea and vomiting.
In Plain Language
Nausea and vomiting prevention injection
Clinical Context
Used for prevention and treatment of chemotherapy-induced and postoperative nausea and vomiting.
RVU Information
CPT J1260 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1260?
CPT J1260 (Dolasetron mesylate) is a J Codes (Drugs) code. Dolasetron mesylate injection, a 5-hydroxytryptamine 3 receptor antagonist for prevention of nausea and vomiting.
How is J1260 administered?
CPT J1260 is administered by a healthcare provider, typically via injection or infusion. Used for prevention and treatment of chemotherapy-induced and postoperative nausea and vomiting. It is used by Oncology, Anesthesiology, Internal Medicine.
When is CPT J1260 used?
Used for prevention and treatment of chemotherapy-induced and postoperative nausea and vomiting.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.